Blepharitis surgery

Jump to navigation Jump to search

Blepharitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Blepharitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Blepharitis surgery On the Web

recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Blepharitis surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Blepharitis surgery

CDC on Blepharitis surgery

Blepharitis surgery in the news

Blogs on Blepharitis surgery

Directions to Hospitals Treating Blepharitis

Risk calculators and risk factors for Blepharitis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Surgical intervention is not the first-line treatment option for patients with blepharitis. Surgery is usually reserved for patients with complications, such as chalazion, entropion, ectropion, or horizontal eyelid laxity.[1][2]

Surgery

Surgery is not the first­line treatment option for patients with blepharitis. Surgery is usually reserved for patients with complications, such as chalazion, entropion, ectropion, or horizontal eyelid laxity.[1][2]

Intraductal Meibomian Gland Probing

Invasive orifice penetration and intraductal probing is usually reserved for patients with severe posterior blepharitis and meibomian gland dysfunction (MGD).[3]

Lipiflow system

LipiFlow, thermal pulsation system, gave rise to significant improvement in both signs and symptoms of patients with meibomian gland dysfunction. LipiFlow provides heat and gentle pressure on the eyelid to liquefy and release obstructions in the meibomian glands.[4]

References

  1. 1.0 1.1 Qiao J, Yan X (2013). "Emerging treatment options for meibomian gland dysfunction". Clin Ophthalmol. 7: 1797–803. doi:10.2147/OPTH.S33182. PMC 3772773. PMID 24043929.
  2. 2.0 2.1 Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T; et al. (2011). "The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction". Invest Ophthalmol Vis Sci. 52 (4): 2050–64. doi:10.1167/iovs.10-6997g. PMC 3072163. PMID 21450919.
  3. Maskin SL (2010). "Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction". Cornea. 29 (10): 1145–52. doi:10.1097/ICO.0b013e3181d836f3. PMID 20622668.
  4. Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR; et al. (2012). "A new system, the LipiFlow, for the treatment of meibomian gland dysfunction". Cornea. 31 (4): 396–404. doi:10.1097/ICO.0b013e318239aaea. PMID 22222996.

Template:WH Template:WS